Clinical Trial Update: Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update discusses a Phase 2/3 study evaluating half-dose ticagrelor versus high-dose clopidogrel in acute coronary syndrome patients with high o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Coronary Artery Disease, Clopidogrel, Poor Metabolism of | Phase 2, Phase 3 | Status: UNKNOWN